News
BSEM
5.05
-11.25%
-0.64
Weekly Report: what happened at BSEM last week (0330-0403)?
Weekly Report · 2d ago
Press Release: BioStem Technologies Announces the Publication of its Audited Financial Statements for Fiscal Years 2024 and 2025
Dow Jones · 03/30 11:02
Weekly Report: what happened at BSEM last week (0323-0327)?
Weekly Report · 03/30 10:33
BioStem Technologies Balances Bold Acquisition With Strain
TipRanks · 03/29 00:04
BioStem Technologies GAAP EPS of -$0.67, revenue of $10.1M
Seeking Alpha · 03/24 20:20
Press Release: BioStem Appoints Jodi Ungrodt to Board of Directors as Audit Committee Chair
Dow Jones · 03/23 11:04
Weekly Report: what happened at BSEM last week (0316-0320)?
Weekly Report · 03/23 10:29
Weekly Report: what happened at BSEM last week (0309-0313)?
Weekly Report · 03/16 10:28
Weekly Report: what happened at BSEM last week (0302-0306)?
Weekly Report · 03/09 10:28
Weekly Report: what happened at BSEM last week (0223-0227)?
Weekly Report · 03/02 10:27
Weekly Report: what happened at BSEM last week (0216-0220)?
Weekly Report · 02/23 10:27
Weekly Report: what happened at BSEM last week (0209-0213)?
Weekly Report · 02/16 10:27
Weekly Report: what happened at BSEM last week (0202-0206)?
Weekly Report · 02/09 10:29
Weekly Report: what happened at BSEM last week (0126-0130)?
Weekly Report · 02/02 10:28
Weekly Report: what happened at BSEM last week (0119-0123)?
Weekly Report · 01/26 10:28
BioStem’s Diabetic Foot Ulcer Trial Reaches Completion: What Investors Should Watch Next
TipRanks · 01/23 16:30
Press Release: BioStem Technologies Advances -2-
Dow Jones · 01/21 22:48
*BioStem Technologies Advances Entry Into The Acute Wound Care Market With Acquisition Of BioTissue Holdings' Surgical And Wound Care Business >BSEM
Dow Jones · 01/21 22:30
Weekly Report: what happened at BSEM last week (0112-0116)?
Weekly Report · 01/19 10:35
Weekly Report: what happened at BSEM last week (0105-0109)?
Weekly Report · 01/12 10:34
More
Webull provides a variety of real-time BSEM stock news. You can receive the latest news about Biostem Tech through multiple platforms. This information may help you make smarter investment decisions.
About BSEM
BioStem Technologies, Inc. is focused on harnessing the natural properties of perinatal tissue in the development, manufacture and commercialization of allografts and regenerative therapies. Leveraging its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The Company's products include VENDAJE, VENDAJE AC, VENDAJE OPTIC and AMERICAN AMNION. VENDAJE is a structural tissue allograft composed of the amnion layer of the placental membrane. VENDAJE is intended for homologous use as a protective covering for soft tissue wounds. VENDAJE AC is a thicker structural tissue allograft composed of the amnion and chorion layer of the placental membrane. VENDAJE AC is intended for homologous use as a protective covering for soft tissue wounds. VENDAJE OPTIC is a structural tissue allograft composed of the amnion layer of the placental membrane. It also owns BioTissue's surgical and wound care business, including the Neox and Clarix product lines.